Company intelligence / Profile preview

Optima Partners

Edinburgh, Scotland, United Kingdomoptima-partners.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Optima Partners is an advanced data science and business consultancy headquartered in Edinburgh. Its health-focused division, bioXcelerate, provides AI-driven platforms such as PleioGraph to accelerate drug discovery and clinical development for pharmaceutical and biotech companies. The firm leverages machine learning/statistics to analyze large-scale biomedical datasets—enabling faster target identification and improved trial design for its clients. It does not develop its own drugs but partners with industry players to enhance R&D productivity.

Therapeutic areas: OncologyRare Diseases
Modalities: Small moleculeBiologicGene therapyCell therapy
Industry: Drug Discovery Services

Partnerships

Major pharmaceutical companies (undisclosed, described as “blue-chip pharma” clients)

Beyond the preview

Go deeper on Optima Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optima Partners.

Explore the full profile